{"id": "1336302034010697729", "creation": 1607434206.0, "user_id": "924711342338064385", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 2, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "text": "UK has issued an emergency-use authorisation for #COVID19 #vaccine developed by #Pfizer-BioNTech, while a 2nd vaccine by Moderna is awaiting similar authorisation. In India, bridging studies will be needed for licensing, says @DrLahariya. Our interview: https://t.co/ycYdbLEc1L", "first_save": 1634559108.199414, "hashtags": ["#COVID19", "#VACCINE", "#PFIZER"]}